Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
Non-Profit Biotech Calls on the Entire ALS Community to Join a Nationwide Network of Independence Day Events CAMBRIDGE, Mass., May 18 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced its BBQ For ALS Awareness , is a national initiative designed to increas...National Ergonomics Conference and Expo Reaches 94% Exhibitor Renewal Rate
New November 17 - 20, 2009 Dates Announced Ergonomics Programs Prove Vital in a Slow Economy NEW YORK, March 5 /PRNewswire/ -- The 15th Annual National Ergonomics Conference and Exposition (NECE) will be held at Caesars Palace, Las Vegas, November 17 - 20, 2009. As of today, nearl...Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
NEW YORK, Dec. 11 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary Percutaneous Hepatic Perfusion ("PHP") System for the treatment of cancers of the liver, announced today that the first fifty percent (46 of 92) of patients h...Covaris Installed Instrument Base Reaches 500 Units
WOBURN, Mass., Nov. 26 /PRNewswire/ -- Covaris Incorporated today announced that during the summer of 2008, the company celebrated the shipment of its 500th instrument unit and continued another successful year throughout 2008. To accommodate this rapid business growth, Covaris is both strengthen...Genmab Reaches Milestone in Ofatumumab Collaboration
Summary: Genmab has Reached the Sixth Milestone in its Ofatumumab Collaboration With GSK. COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms ...Genmab Reaches Fifth Milestone in Ofatumumab Collaboration
Summary: Genmab Will Receive a Milestone Payment of Approximately DKK 232.7 Million From GSK for Achievement of Positive Results in the Phase III CLL Study COPENHAGEN, August 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the fi...Migenix averts proxy contest; reaches agreement with DJohnson holdings
VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ - MIGENIX Inc. ("MIGENIX") announced today that it has reached an agreement with DJohnson Holdings Inc. ("DJohnson"), a significant shareholder of MIGENIX, that will avoid a proxy contest at MIGENIX's annual meeting of shareholders scheduled for Octobe...AMERIGROUP Reaches Agreement in Principle to Settle Illinois Qui Tam Litigation
VIRGINIA BEACH, Va., July 22 /PRNewswire-FirstCall/ -- AMERIGROUP Corporation (NYSE: AGP ) announced today that it has reached a comprehensive settlement agreement in principle that will conclude its civil qui tam litigation relating to certain marketing practices of the Company's former Illi...Advanced Bionics Reaches Resolution With FDA, Settles Financial Suit
VALENCIA, Calif., July 18 /PRNewswire/ -- Advanced Bionics agreed to settle an administrative complaint arising from a disagreement with the U.S. Food and Drug Administration (FDA). The FDA asserted that Advanced Bionics should have made a formal submission five years ago before using a second...Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial
Pivotal Trial in Medullary Thyroid Cancer Planned to Initiate This Summer SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL ) announced today that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registr...PAREXEL Reaches Agreement To Acquire ClinPhone
Combined Capabilities to Create One of the Industry's Largest eClinical Technology Offerings BOSTON, June 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services organization, today announced that the...Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR
HILTON HEAD ISLAND, S.C., April 1 /PRNewswire/ -- Dr. Roger Kenneth Hershline, PhD, MD, the CEO of Global Humanceuticals, Inc. and founder and chairman of the not-for-profit public charity CureHIV.us, announces today that he is reaching out to the funder community, including funding initiative...China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
HANGZHOU, China, March 26 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) announced today that it has reached agreement with Beijing Keyuan Xinhai Pharmaceutical Company to launch newly approved pharmaceutical products made by leading international pharmaceutical com...R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
WASHINGTON, March 24 /PRNewswire-USNewswire/ -- America's pharmaceutical and biotechnology research companies invested a record $58.8 billion last year in the research and development of new life-changing medicines and vaccines -- an increase of nearly $3 billion from 2006, according to analys...Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
WASHINGTON and SAN DIEGO, March 17 /PRNewswire/ -- Even as investors maintain their strong interest in the life sciences sector, industry stakeholders are facing tough decisions, according to Pillsbury attorneys. "Despite the current credit crunch in the U.S., life science organizations span...Fralex reaches 100th patient milestone in fibromyalgia study
- Interim analysis results expected in Q3 2008 - TORONTO, March 10 /PRNewswire-FirstCall/ - Fralex Therapeutics Inc. (TSX:FXI) ("Fralex" or the "Company"), a medical technology company developing a non-invasive neuromodulation device, today announced the randomization of the 100th ...Genmab Reaches Milestones in Ofatumumab Collaboration
Summary: Genmab has Achieved Two Development Milestones in its Ofatumumab Collaboration With GlaxoSmithKline. COPENHAGEN, January 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the second and third development milestones for ofatumumab (HuMax-...Pharsight's Reporting and Analysis Services Business Reaches Quality Assurance Milestone
New Consulting Unit Hosts Three Customer Audits, Continues Growth Strategy That Leverages Pharsight's Industry-Leading Software Tools MOUNTAIN VIEW, Calif., Dec. 20 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST ), a leading provider of software, strategic consulting, and ...Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
AUSTIN, Texas, Oct. 15 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX ) today announced that it has settled the pending litigation with Rules Based Medicine, Inc ("RBM"). As part of the settlement, Luminex received a cash payment of $12.5 million. The cash payment was made by RBM...Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
VANCOUVER, Sept. 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), announced today that it reached a favourable agreement with Johnson & Johnson's subsidiary, Conor Medsystems ("Conor") to settle all outstanding patent litigation with respect to Conor's Co...Learning how far your message reaches by Googling yourself
CHICAGOIf you buy into the concept that any ink is good ink and if you believe that name and brand recognition is the first step to sales, then its worth a couple minutes a month to Google yourself. I have a huge media department. Its almost an entire hanging file folder in my office and an ...Biotech industry reaches midpoint in 50-year maturation cycle
If we assume that the biotech industry started in the late 1970s with the first IPOs taking place in 1980 (Amgen and Cetus), then biotech is already an industry more than 25 years old. An interesting article in Genetic Engineering News ( GEN ) on March 1 states unequivocally that most indust...Global information firm reaches diverse markets
Madison, Wis. - Dan Rooney knows soil. He also knows how to build a viable business. And seven years after starting his Madison-based company, his ideas about turning landscape data into packaged products have gone global. "There is information about location everywhere," said Rooney, founder ...TomoTherapy's 100th radiology system reaches public sector
Madison, Wis. - TomoTherapy, Inc. has reached the public sector with the sale of its 100 th Hi-Art radiology system. The Stratton VA Medical Center in Albany, N.Y., a hospital under the U.S. Department of Veterans Affairs , now is treating patients with TomoTherapy's cancer-targeting sys...Avolte Venture Partners reaches capital goal
Madison, Wis. - Avolte Venture Partners Midwest, a venture capital arm of Boston's Peak Ridge Capital Group, Inc. , says it has reached its initial goal for raising capital and is ready to scout for early-stage investments in Wisconsin and the Midwest. The fund, which was to be capped at $50 ...Douglas Stewart reaches distribution pact with digital video firm
Madison, Wis. - The Douglas Stewart Co. has entered into a distribution agreement to offer to its network of education resellers the products of Honestech, Inc. , an Austin, Texas supplier of digital video and Internet Protocol (IP) communication and entertainment products. Financial terms ...New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World
...w life is the key to understanding the universe. The Huffington Post is ranked the most powerful (and most widely referenced) blog in the world. It reaches over 20 million thought-leaders, and has featured celebrity contributors from politics to business and entertainment, including President Barack Obama...TechNet Urges Swift U.S. Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell
...e two extremely capable public servants and look forward to working with them on the vitally important issues of making sure the power of the Internet reaches all our citizens and grows our economy." Mr. Genachowski will bring more than two decades of public and private-sector experience to the Commiss...LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
... regulate angiogenesis, cell metabolism, cell proliferation, cell death (apoptosis) and cell invasion. HIF-1 alpha protein is low in normal cells, but reaches high intracellular concentrations in a variety of cancers and is strongly correlated with poor prognosis and resistance to therapy. Enzon is currently...AutoImmune Inc. Reports 2009 First Quarter Financial Results
...y diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug, dirucotide (formerly referred to as MBP8298), if it reaches the market. In December 2007, BioMS sublicensed its rights in this product to Eli Lilly and Company. The FDA has granted the product fast track desi...